WO2019218594A1 - Nanoparticule phosphorescente hydrosoluble pour la détection d'acide hypochloreux à l'aide d'un procédé de rapport et procédé de préparation et application associés - Google Patents
Nanoparticule phosphorescente hydrosoluble pour la détection d'acide hypochloreux à l'aide d'un procédé de rapport et procédé de préparation et application associés Download PDFInfo
- Publication number
- WO2019218594A1 WO2019218594A1 PCT/CN2018/111540 CN2018111540W WO2019218594A1 WO 2019218594 A1 WO2019218594 A1 WO 2019218594A1 CN 2018111540 W CN2018111540 W CN 2018111540W WO 2019218594 A1 WO2019218594 A1 WO 2019218594A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- hypochlorous acid
- water
- nanoparticle
- soluble
- complex
- Prior art date
Links
- 239000002105 nanoparticle Substances 0.000 title claims abstract description 53
- QWPPOHNGKGFGJK-UHFFFAOYSA-N hypochlorous acid Chemical compound ClO QWPPOHNGKGFGJK-UHFFFAOYSA-N 0.000 title claims abstract description 44
- 238000000034 method Methods 0.000 title claims abstract description 21
- 238000002360 preparation method Methods 0.000 title description 10
- 239000002202 Polyethylene glycol Substances 0.000 claims abstract description 4
- 229920001223 polyethylene glycol Polymers 0.000 claims abstract description 4
- 239000000243 solution Substances 0.000 claims description 18
- 150000001875 compounds Chemical class 0.000 claims description 13
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 12
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 12
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 12
- 238000001514 detection method Methods 0.000 claims description 11
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 10
- 239000007787 solid Substances 0.000 claims description 10
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 9
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 claims description 8
- 238000004440 column chromatography Methods 0.000 claims description 7
- HZNVUJQVZSTENZ-UHFFFAOYSA-N 2,3-dichloro-5,6-dicyano-1,4-benzoquinone Chemical compound ClC1=C(Cl)C(=O)C(C#N)=C(C#N)C1=O HZNVUJQVZSTENZ-UHFFFAOYSA-N 0.000 claims description 6
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 6
- 239000003446 ligand Substances 0.000 claims description 5
- 229910052757 nitrogen Inorganic materials 0.000 claims description 5
- 238000011895 specific detection Methods 0.000 claims description 5
- 239000011259 mixed solution Substances 0.000 claims description 4
- 239000000203 mixture Substances 0.000 claims description 4
- 229910000027 potassium carbonate Inorganic materials 0.000 claims description 4
- 238000000967 suction filtration Methods 0.000 claims description 4
- 239000000839 emulsion Substances 0.000 claims description 3
- 239000012299 nitrogen atmosphere Substances 0.000 claims description 3
- 150000003904 phospholipids Chemical class 0.000 claims description 3
- 238000000108 ultra-filtration Methods 0.000 claims description 3
- 206010061218 Inflammation Diseases 0.000 claims description 2
- 238000001727 in vivo Methods 0.000 claims description 2
- 238000011503 in vivo imaging Methods 0.000 claims description 2
- 230000004054 inflammatory process Effects 0.000 claims description 2
- 238000000926 separation method Methods 0.000 claims description 2
- 150000002503 iridium Chemical class 0.000 abstract 1
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 27
- WQYVRQLZKVEZGA-UHFFFAOYSA-N hypochlorite Chemical compound Cl[O-] WQYVRQLZKVEZGA-UHFFFAOYSA-N 0.000 description 26
- 238000012360 testing method Methods 0.000 description 17
- 238000005481 NMR spectroscopy Methods 0.000 description 8
- 239000000523 sample Substances 0.000 description 8
- SUKJFIGYRHOWBL-UHFFFAOYSA-N sodium hypochlorite Chemical compound [Na+].Cl[O-] SUKJFIGYRHOWBL-UHFFFAOYSA-N 0.000 description 8
- 238000000862 absorption spectrum Methods 0.000 description 7
- 238000006243 chemical reaction Methods 0.000 description 7
- 239000012327 Ruthenium complex Substances 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 238000002474 experimental method Methods 0.000 description 5
- 238000003384 imaging method Methods 0.000 description 5
- 239000002904 solvent Substances 0.000 description 4
- 238000004448 titration Methods 0.000 description 4
- 102000003896 Myeloperoxidases Human genes 0.000 description 3
- 108090000235 Myeloperoxidases Proteins 0.000 description 3
- 239000005708 Sodium hypochlorite Substances 0.000 description 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 238000010226 confocal imaging Methods 0.000 description 3
- 231100000135 cytotoxicity Toxicity 0.000 description 3
- 230000003013 cytotoxicity Effects 0.000 description 3
- 239000007850 fluorescent dye Substances 0.000 description 3
- 230000003834 intracellular effect Effects 0.000 description 3
- 238000004020 luminiscence type Methods 0.000 description 3
- 230000001590 oxidative effect Effects 0.000 description 3
- 239000001301 oxygen Substances 0.000 description 3
- 229910052760 oxygen Inorganic materials 0.000 description 3
- 230000004044 response Effects 0.000 description 3
- 230000003595 spectral effect Effects 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 238000004847 absorption spectroscopy Methods 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 239000010949 copper Substances 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000000295 emission spectrum Methods 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- 230000036542 oxidative stress Effects 0.000 description 2
- 230000001766 physiological effect Effects 0.000 description 2
- 239000003642 reactive oxygen metabolite Substances 0.000 description 2
- 238000011897 real-time detection Methods 0.000 description 2
- 150000003303 ruthenium Chemical class 0.000 description 2
- 150000003384 small molecules Chemical class 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 1
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010047115 Vasculitis Diseases 0.000 description 1
- 230000003044 adaptive effect Effects 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 239000012491 analyte Substances 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000012472 biological sample Substances 0.000 description 1
- 229910002091 carbon monoxide Inorganic materials 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 238000002784 cytotoxicity assay Methods 0.000 description 1
- 231100000263 cytotoxicity test Toxicity 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 238000002296 dynamic light scattering Methods 0.000 description 1
- 238000004993 emission spectroscopy Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 231100000086 high toxicity Toxicity 0.000 description 1
- 230000036571 hydration Effects 0.000 description 1
- 238000006703 hydration reaction Methods 0.000 description 1
- CUILPNURFADTPE-UHFFFAOYSA-N hypobromous acid Chemical class BrO CUILPNURFADTPE-UHFFFAOYSA-N 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 238000011246 intracellular protein detection Methods 0.000 description 1
- 238000005342 ion exchange Methods 0.000 description 1
- 208000032839 leukemia Diseases 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000008204 material by function Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 201000008383 nephritis Diseases 0.000 description 1
- 238000010899 nucleation Methods 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000004962 physiological condition Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000012113 quantitative test Methods 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 238000011896 sensitive detection Methods 0.000 description 1
- 238000004611 spectroscopical analysis Methods 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 230000000451 tissue damage Effects 0.000 description 1
- 231100000827 tissue damage Toxicity 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 229910052723 transition metal Inorganic materials 0.000 description 1
- 150000003624 transition metals Chemical class 0.000 description 1
- 238000004627 transmission electron microscopy Methods 0.000 description 1
- 229910021642 ultra pure water Inorganic materials 0.000 description 1
- 239000012498 ultrapure water Substances 0.000 description 1
- 238000002525 ultrasonication Methods 0.000 description 1
- 238000001392 ultraviolet--visible--near infrared spectroscopy Methods 0.000 description 1
- 229920003169 water-soluble polymer Polymers 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/6402—Atomic fluorescence; Laser induced fluorescence
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
- C07F15/0006—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table compounds of the platinum group
- C07F15/0033—Iridium compounds
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K11/00—Luminescent, e.g. electroluminescent, chemiluminescent materials
- C09K11/06—Luminescent, e.g. electroluminescent, chemiluminescent materials containing organic luminescent materials
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
- C09K2211/18—Metal complexes
- C09K2211/185—Metal complexes of the platinum group, i.e. Os, Ir, Pt, Ru, Rh or Pd
Definitions
- the invention belongs to the technical field of organic photoelectric functional materials, and particularly relates to a water-soluble phosphorescent nano particle which can be used for detecting hypochlorous acid by a ratio method, a preparation method thereof and an application of the nano particle to detect hypochlorous acid in the living body.
- Active oxygen is a general term for a series of chemically active and oxidizing oxygen-containing substances produced by organisms.
- Reactive oxygen contains both free radicals and some non-free radicals such as hydrogen peroxide (H 2 O 2 ), hypochlorous acid (HClO), hydroxyl radicals (HO ⁇ ) and singlet oxygen ( 1 O 2 ).
- Reactive oxygen species play an important role in biological systems.
- HClO is a relatively common reactive oxygen species.
- the endogenous HClO is mediated by myeloperoxidase (MPO).
- MPO myeloperoxidase
- ClO - has high reactivity, short life span and more physiological activity. The process is an important and powerful oxidant that exerts an anti-microbial effect under physiological conditions and protects the body. Studies have shown that HClO is also a natural adaptive immune adjuvant. However, under certain conditions, if the excess of HClO produced by the MPO catalytic reaction exceeds the defense reaction of the local antioxidant, it will cause oxidative stress and oxidative tissue damage.
- Oxidative stress caused by excessive HClO has been shown to be associated with various diseases such as leukemia, nephritis, small vasculitis, tumors and atherosclerosis. Therefore, rapid, sensitive and real-time detection of hypochlorous acid has important physiological and pathological effects, which can provide reliable information for the pathogenesis, diagnosis and intervention of diseases.
- Phosphorescent transition metal complexes such as Pt(II)-, Ir(III)-, Ru(II)-, Cu(I)-, Au(I)-, etc., have been used in the field of living cell imaging in recent years. To gradually attract people's attention.
- the ruthenium complex exhibits special photoelectric properties in charge transfer and energy transfer between the metal center and the ligand, and has the advantages of high-efficiency triplet phosphorescence emission, long life, and large Stokes shift. It has not been found to be significantly toxic to cells and has great potential for application in cell biology imaging.
- the present invention aims to provide a water-soluble phosphorescent nanoparticle capable of detecting hypochlorous acid by a ratio method and to disclose a preparation method thereof and related applications, and the ratio method can reduce interference factors and accurately and specifically detect hypochlorous acid.
- the nanoparticle has excellent water solubility and biocompatibility, and has good application prospects in the fields of intracellular detection and living body detection.
- a water-soluble phosphorescent nanoparticle for detecting hypochlorous acid by a ratio method characterized in that the structure is as follows:
- C ⁇ N ligand in Ir(1-9) is any one of the following:
- the N ⁇ N ligand in Ir(1-6) * is any one of the following:
- water-soluble phosphorescent nanoparticles can be used for specific detection of hypochlorous acid by a ratio method.
- water-soluble phosphorescent nanoparticles can be used in the field of cell sensing and in vivo imaging sensing.
- water soluble phosphorescent nanoparticles can be used to establish a model of in vivo inflammation.
- the invention has the beneficial effects that the present invention prepares a water-soluble phosphorescent nanoparticle by solving the problems of poor biocompatibility, poor water solubility, short life span and high toxicity of the small molecule hypochlorous acid probe in the prior art.
- the nanoparticle binding ratio method realizes self-calibration, and can specifically detect the change of hypochlorous acid content; has a long emission life, combines time-resolved technology to eliminate interference of background fluorescent signal, and improves detection signal-to-noise ratio; meanwhile, the nanoparticle has Good water solubility and biocompatibility, can detect intracellular hypochlorous acid; low toxicity, less damage to biological samples, can achieve detection of hypochlorous acid in the living field.
- Example 1 is a responsive ultraviolet absorption spectrum of ruthenium complex Ir1 to hypochlorite in Example 4 of the present invention
- Figure 2 is a responsive ultraviolet absorption spectrum of ruthenium complex Ir1* to hypochlorite in Example 4 of the present invention
- Figure 3 is the embodiment Ir1-ClO 5 * Ir1 embodiment of the present invention, hypochlorous acid in response - emission spectrum;
- Example 6 is a statistical diagram showing ion exchange experiment results of Ir1 and Ir1* in Example 6 of the present invention
- Example 7 is a TEM test chart of phosphorescent water-soluble nanoparticle Ir NPs in Example 7 of the present invention.
- Example 6 is a DLS test chart of phosphorescent water-soluble nanoparticle Ir NPs in Example 8 of the present invention.
- Figure 7 is an absorption spectrum diagram of the complexes Ir1, Ir1* and the nanoparticles Ir NPs in Example 9 of the present invention.
- Figure 8 is a graph showing the titration spectrum of phosphorescent water-soluble nanoparticle Ir NPs in Example 10 of the present invention.
- Figure 9 is a test chart showing the relationship between the ratio of two emission peaks (I 600 /I 680 ) in the titration emission spectrum of the phosphorescent water-soluble nanoparticle Ir NPs according to the concentration of NaClO in the tenth embodiment of the present invention
- Figure 10 is a graph showing the experimental results of MTT cytotoxicity of phosphorescent water-soluble nanoparticle Ir NPs in Example 11 of the present invention.
- Figure 11 is a cell confocal imaging map of phosphorescent water-soluble nanoparticle Ir NPs in Example 12 of the present invention.
- the chemical reagents used in the present invention are all commercially available.
- the instruments used include:
- UV spectrometer UV-3600 UV-VIS-NIR, Shimadzu
- the probe complex Ir1 (1.0 mg) and the reference complex Ir1* (0.9 mg) were dissolved in a certain amount of tetrahydrofuran (2.0 mL), and a solution of 10.0 mg of phospholipid polyethylene glycol in PBS (10.0 mL) was added. Mix quickly and sonicate for 2.0 min. Then, the mixture was purged with a nitrogen balloon to tetrahydrofuran, and finally centrifuged in an ultrafiltration centrifuge tube to obtain an orange-red emulsion product, which was lyophilized to obtain an orange-red solid, that is, a nanoparticle Ir NPs.
- the ruthenium complex Ir1, Ir1* used in the present invention has a spectral test concentration of 10 ⁇ M, and the test solvent is a PBS solution mixed with 1% DMSO.
- Figure 1 is a UV absorption spectrum of the probe complex Ir1 after adding different concentrations of hypochlorite.
- Example 5 Responsive emission spectroscopy of hypobromite complexes Ir1 and Ir1*
- the ruthenium complex Ir1, Ir1* used in the present invention has a spectral test concentration of 10 ⁇ M, and the test solvent is a PBS solution mixed with 1% DMSO.
- the hypochlorite was 5 times the equivalent concentration, the response time was 1 minute, the remaining ions were 20 times the equivalent concentration, and the response time was 5 minutes.
- the results are shown in Fig. 4.
- the intensity of the emission peak of the reference complex Ir1* at 680 nm is almost constant, and the emission of the probe complex Ir1 at 680 nm is obtained.
- the peak is specifically illuminated by hypochlorite. Therefore, Ir1* can be used as a reference and imaged with the Ir1 construction ratio method for specific detection of changes in hypochlorite.
- Example 7 TEM test of phosphorescent water-soluble nanoparticle Ir NPs
- the phosphorescent water-soluble nanoparticle Ir NPs was dissolved in ethanol, dropped on a copper mesh, and subjected to TEM test after being naturally volatilized. As a result, as shown in Fig. 5, the nanoparticles were regular in shape, uniform in distribution, and all of them were circular, and the particle radius was about 105 nm.
- Example 8 DLS test of phosphorescent water-soluble nanoparticle Ir NPs
- the phosphorescent water-soluble nanoparticle Ir NPs was dissolved in ultrapure water, and the bubbles were removed by ultrasonication, and the DLS test was performed. As a result, as shown in Fig. 6, the nanoparticles were concentrated and had a hydration kinetic radius of about 125 nm.
- Example 9 Absorption spectroscopy test of complex Ir1, Ir1* and nanoparticle Ir NPs
- the ruthenium complexes Ir1 and Ir1* used in the present invention have a spectral concentration of 10 ⁇ M
- the test solvent is a PBS solution mixed with 1% DMSO
- the nanoparticles Ir NPs is 1 mg/mL
- the test solvent is a PBS solution.
- the ultraviolet absorption spectrum of the nanoparticle Ir NPs contains characteristic absorption peaks of the ruthenium complexes Ir1 and Ir1*.
- Example 11 MTT cytotoxicity assay of phosphorescent water-soluble nanoparticle Ir NPs
- the digested cells were seeded in a 96-well plate at a seeding density of 10 4 cells/well per well, and culture was continued for 24 hours at 37 ° C under 5% CO 2 . After the old culture solution was aspirated, the cells were further cultured for 24 hours with cell culture solutions of different concentrations of Ir NPs (10, 50, 100, 200, 300 ⁇ g/mL). The culture was terminated by adding 10 ⁇ L of MTT (5 mg/mL) to each well and continuing the culture for 4 hours. The culture solution was aspirated, 150 ⁇ L of DMSO was added to each well, and the shaker was shaken for 10 minutes, and then the OD570 was tested using a microplate reader.
- Fig. 10 The results of the MTT cytotoxicity experiment are shown in Fig. 10. It can be seen from the figure that when the concentration of the complex is 10 to 300 ⁇ g/mL, the cell survival rate after 24 hours of culture is greater than 90%, which proves that the nanoparticles have a lower concentration. Cytotoxicity can be used for cell imaging.
- Example 12 Confocal imaging experiment of phosphorescent water-soluble nanoparticle Ir NPs
- the cell confocal imaging experiment of the nanoparticles Ir NPs the experimental results are shown in Figure 11, using a concentration of 10 ⁇ g / mL.
- the specific procedure was to incubate HeLa cells in a 37 ° C incubator for 24 hours, then incubate HeLa cells with nanoparticle Ir NPs for 1 hour at 37 ° C, and then incubate with different concentrations of hypochlorous acid culture. Confocal testing was performed at the end of the incubation. The test results are shown in Fig. 11. The luminescence of the green channel increases with the increase of sodium hypochlorite concentration, while the luminescence of the red channel does not change significantly.
- the ratio of I 600nm /I 680nm increases with the increase of sodium hypochlorite. It is therefore possible to monitor changes in intracellular sodium hypochlorite by monitoring the luminescence and the ratio of the two. It is indicated that the phosphorescent water-soluble nanoparticle Ir NPs can specifically detect intracellular hypochlorous acid by ratiometric method combined with cell life imaging.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Physics & Mathematics (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Optics & Photonics (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
Abstract
L'invention concerne une nanoparticule phosphorescente hydrosoluble pour la détection d'acide hypochloreux à l'aide d'un procédé de rapport, constituée de complexes d'iridium Ir(1‑9) et Ir(1‑6)* et de phospholipide-polyéthylène glycol. L'Ir(1‑9) peut répondre spécifiquement à l'acide hypochloreux, et l'Ir(1‑6)* est utilisé en tant que complexe de référence et ne répond pas à l'acide hypochloreux. L'invention concerne également un procédé de préparation d'une nanoparticule phosphorescente hydrosoluble.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810473705.3 | 2018-05-17 | ||
CN201810473705.3A CN108535233B (zh) | 2018-05-17 | 2018-05-17 | 一种用于比率法检测次氯酸的水溶性磷光纳米粒子及其制备方法与应用 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2019218594A1 true WO2019218594A1 (fr) | 2019-11-21 |
Family
ID=63472053
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/CN2018/111540 WO2019218594A1 (fr) | 2018-05-17 | 2018-10-24 | Nanoparticule phosphorescente hydrosoluble pour la détection d'acide hypochloreux à l'aide d'un procédé de rapport et procédé de préparation et application associés |
Country Status (2)
Country | Link |
---|---|
CN (1) | CN108535233B (fr) |
WO (1) | WO2019218594A1 (fr) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108535233B (zh) * | 2018-05-17 | 2020-07-17 | 南京邮电大学 | 一种用于比率法检测次氯酸的水溶性磷光纳米粒子及其制备方法与应用 |
CN111233754B (zh) * | 2020-01-19 | 2023-06-02 | 广东省生物工程研究所(广州甘蔗糖业研究所) | 基于铂配合物的磷光探针及其在次氯酸检测中的应用 |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007100061A1 (fr) * | 2006-03-03 | 2007-09-07 | The University Of Tokyo | Sonde fluorescente |
CN103342697A (zh) * | 2013-07-05 | 2013-10-09 | 中国科学院合肥物质科学研究院 | 一种用于检测次氯酸的双功能近红外荧光分子探针及其制备方法 |
CN103555321A (zh) * | 2013-10-30 | 2014-02-05 | 南京邮电大学 | 一种磷光离子型铱配合物探针及其制备方法和应用 |
CN108102645A (zh) * | 2017-12-12 | 2018-06-01 | 南京邮电大学 | 一种用于次氯酸根离子检测的荧光探针的制备及应用 |
CN108218923A (zh) * | 2018-03-06 | 2018-06-29 | 南京邮电大学 | 一种检测pH的水溶性磷光聚合物及其制备方法和应用 |
CN108535233A (zh) * | 2018-05-17 | 2018-09-14 | 南京邮电大学 | 一种用于比率法检测次氯酸的水溶性磷光纳米粒子及其制备方法与应用 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3483610A1 (fr) * | 2009-11-09 | 2019-05-15 | University Of Washington Center For Commercialization | Points de polymère chromophore fonctionnalisé et leurs bioconjugués |
CN102206235A (zh) * | 2011-03-18 | 2011-10-05 | 南京邮电大学 | 可溶于水体系的磷光铱配合物及其制备方法 |
US9788765B2 (en) * | 2012-09-28 | 2017-10-17 | Dexcom, Inc. | Zwitterion surface modifications for continuous sensors |
WO2016015027A1 (fr) * | 2014-07-25 | 2016-01-28 | SeLux Diagnostics, Inc. | Procédés d'analyse impliquant des nanoparticules dissociables |
CN106046059B (zh) * | 2016-06-06 | 2018-08-17 | 南京邮电大学 | 一种具有线粒体靶向功能的磷光铱配合物探针及其制备和应用 |
CN106281308A (zh) * | 2016-07-29 | 2017-01-04 | 南京邮电大学 | 一种包覆离子型铱配合物的聚合物纳米粒子及其制备方法和应用 |
CN106892947B (zh) * | 2017-02-28 | 2019-07-30 | 陕西师范大学 | 一种含有(肼基羰基)二茂铁配体的铱配合物及其制备方法和应用 |
-
2018
- 2018-05-17 CN CN201810473705.3A patent/CN108535233B/zh active Active
- 2018-10-24 WO PCT/CN2018/111540 patent/WO2019218594A1/fr active Application Filing
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007100061A1 (fr) * | 2006-03-03 | 2007-09-07 | The University Of Tokyo | Sonde fluorescente |
CN103342697A (zh) * | 2013-07-05 | 2013-10-09 | 中国科学院合肥物质科学研究院 | 一种用于检测次氯酸的双功能近红外荧光分子探针及其制备方法 |
CN103555321A (zh) * | 2013-10-30 | 2014-02-05 | 南京邮电大学 | 一种磷光离子型铱配合物探针及其制备方法和应用 |
CN108102645A (zh) * | 2017-12-12 | 2018-06-01 | 南京邮电大学 | 一种用于次氯酸根离子检测的荧光探针的制备及应用 |
CN108218923A (zh) * | 2018-03-06 | 2018-06-29 | 南京邮电大学 | 一种检测pH的水溶性磷光聚合物及其制备方法和应用 |
CN108535233A (zh) * | 2018-05-17 | 2018-09-14 | 南京邮电大学 | 一种用于比率法检测次氯酸的水溶性磷光纳米粒子及其制备方法与应用 |
Also Published As
Publication number | Publication date |
---|---|
CN108535233A (zh) | 2018-09-14 |
CN108535233B (zh) | 2020-07-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Wang et al. | A Hydrogen‐Bonded‐Supramolecular‐Polymer‐Based Nanoprobe for Ratiometric Oxygen Sensing in Living Cells | |
WO2019218594A1 (fr) | Nanoparticule phosphorescente hydrosoluble pour la détection d'acide hypochloreux à l'aide d'un procédé de rapport et procédé de préparation et application associés | |
Su et al. | AIE-based Tb3+ complex self-assembled nanoprobe for ratiometric fluorescence detection of anthrax spore biomarker in water solution and actual spore samples | |
CN110128414B (zh) | 一种基于半花菁染料的缺氧荧光探针的制备和应用 | |
CN106084873B (zh) | 一种高效近红外荧光材料及其生物应用 | |
CN113135906A (zh) | 一种能够特异性检测脂滴内极性变化的脂滴靶向荧光探针 | |
CN115386371B (zh) | 蓝色荧光量子点制备方法及作为谷胱甘肽检测探针的应用 | |
Zhang et al. | Selective visualization of endogenous hydrogen sulfide in lysosomes using aggregation induced emission dots | |
KR20110120224A (ko) | 수용성 형광 풀러렌 유도체 및 그 제조방법 | |
Zhao et al. | Self-enhanced carbonized polymer dots for selective visualization of lysosomes and real-time apoptosis monitoring | |
Khan et al. | Solvent-free synthesis of nitrogen doped carbon dots with dual emission and their biological and sensing applications | |
US20070092927A1 (en) | Photocatalytic particles with directed and controlled redox activity | |
CN113201335B (zh) | 一种增强型荧光碳点及制备方法和在镉离子检测中的应用 | |
CN113604213B (zh) | 纳米荧光探针及其制备方法和应用 | |
Liu et al. | Hydrothermal synthesis of a highly photoluminescent molecule from citric acid and cysteamine for the efficient detection of Au3+ in aqueous solution | |
Zhang et al. | In vivo selective imaging of metabolic glycosylation with a tetrazine-modified upconversion nanoprobe | |
CN110372681B (zh) | 一种用于选择性检测人血清白蛋白的自组装纳米荧光探针的应用 | |
CN110669503B (zh) | 一种一氧化碳近红外荧光探针的制备和应用 | |
Sun et al. | One-pot synthesis of conjugated polymer dots with ultrasmall size below 10 nm through Schiff-base chemistry and their bioapplications in monitoring lysosomal pH | |
Gao et al. | One-pot synthesis of efficient multifunctional nitrogen-doped carbon dots with efficient yellow fluorescence emission for detection of hypochlorite and thiosulfate | |
Shen et al. | A one-step synthesis of novel high pH-sensitive nitrogen-doped yellow fluorescent carbon dots and their detection application in living cells | |
CN110117236A (zh) | 一种以ts为荧光团的小分子荧光探针及其制备方法与应用 | |
CN113024504B (zh) | 基于异佛尔酮-氧杂蒽的硫化氢荧光探针的制备和应用 | |
Li et al. | A platinum (II)-acetylide-based conjugated polyelectrolyte for hypoxia imaging via ratiometric and time-resolved luminescence microscopy | |
CN112239462B (zh) | 基于香豆素和羧酸吲哚的氰根受体化合物、制备方法及其应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 18918818 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 18918818 Country of ref document: EP Kind code of ref document: A1 |